We are live on
!
Find out more
HA
Harfst & Associates Portfolio holdings
AUM
$643M
1-Year Est. Return
24.12%
This Fund
S&P 500
This Quarter
Est. Return
+7.98%
1 Year Est. Return
+24.12%
3 Year Est. Return
+82.48%
5 Year Est. Return
+108.64%
10 Year Est. Return
+384.36%
AUM
$190M
AUM Growth
-$58.1M
(-23%)
Cap. Flow
-$71.2M
Cap. Flow
% of AUM
-37.52%
Top 10 Holdings %
Top 10 Hldgs %
83.31%
Holding
104
New
3
Increased
18
Reduced
42
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.84M |
| 2 |
Vanguard Real Estate ETF
VNQ
|
+$1.29M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$1.29M |
| 4 |
Schwab US Mid-Cap ETF
SCHM
|
+$1.11M |
| 5 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$743K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.3M |
| 2 |
Stryker
SYK
|
+$2.21M |
| 3 |
RTN
Raytheon Company
RTN
|
+$2.19M |
| 4 |
General Dynamics
GD
|
+$2.17M |
| 5 |
Medtronic
MDT
|
+$2.16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 39.97% |
| 2 | Consumer Staples | 5.39% |
| 3 | Technology | 1.75% |
| 4 | Healthcare | 1.45% |
| 5 | Consumer Discretionary | 1.27% |
Similar funds
CRCM
PCM
GECH
APC
RR
WHGAM
SFG
SCP
Harfst & Associates's Q3 2016 Portfolio in Review
As of Q3 2016, Harfst & Associates held 104 positions worth $190M, down 23% from $248M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Harfst & Associates withdrew a net $71.2M in Q3 2016, closing 30 positions and reducing 42 holdings. Its most notable exit was Eli Lilly, an estimated $2.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 40% of assets, up from 29% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, Harfst & Associates opened a new position in iShares Core US Aggregate Bond ETF worth $365K.
- Harfst & Associates's largest Q3 2016 buy was iShares Core US Aggregate Bond ETF: 3,249 shares worth $365K.
- Harfst & Associates added most to iShares Core S&P 500 ETF in Q3 2016, an estimated $1.84M increase.
- Harfst & Associates's biggest Q3 2016 reduction was Stryker, cutting an estimated $2.21M.
- Harfst & Associates fully exited Eli Lilly in Q3 2016, selling an estimated $2.3M.
- Harfst & Associates's ten largest holdings make up 83% of its $190M portfolio in Q3 2016.
- Harfst & Associates opened 3 new positions and closed 30 in Q3 2016.
- Harfst & Associates's portfolio value fell 23% quarter-over-quarter to $190M.
Based on Harfst & Associates's 13F filing for Q3 2016, filed 14 Nov 2016.